DDAH activity is not associated with oxidative stress in elderly patients with peripheral arterial occlusive disease

Experimental Gerontology

Volumn 55, Issue , 2014, Pages 159-160

  Schneider, Jessica Y ^a   Pham, Vu Vi ^a   Frölich, Jürgen C ^a   Tsikas, Dimitrios ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; CACODYLIC ACID; CREATININE; DIMETHYLARGININASE; MALONALDEHYDE; NITRIC OXIDE;

AGE; AGED; AMINO ACID BLOOD LEVEL; AMINO ACID URINE LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LETTER; MASS SPECTROMETRY; NONHUMAN; OXIDATIVE STRESS; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; AGING; ANIMAL; LIVER; MALE; METABOLISM; REPERFUSION INJURY;

AGING; ANIMALS; LIVER; MALE; NITRIC OXIDE; REPERFUSION INJURY;

EID: 84900022377     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2014.03.012     Document Type: Letter

References (10)

1. Becker T., Mevius I., de Vries D.K., Schaapherder A.F., zu Vilsendorf A.M., Klempnauer J., Frölich J.C., Tsikas D. The L-arginine/NO pathway in end-stage liver disease and during orthotopic liver and kidney transplantation: biological and analytical ramifications. Nitric Oxide 2009, 20(1):61-67.
2. Chobanyan K., Thum T., Suchy M.T., Zhu B., Mitschke A., Gutzki F.M., Beckmann B., Stichtenoth D.O., Tsikas D. GC-MS assay for hepatic DDAH activity in diabetic and non-diabetic rats by measuring dimethylamine (DMA) formed from asymmetric dimethylarginine (ADMA): evaluation of the importance of S-nitrosothiols as inhibitors of DDAH activity in vitro and in vivo in humans. J. Chromatogr. B 2007, 858(1-2):32-41.
3. de Vries D.K., Kortekaas K.A., Tsikas D., Wijermars L.G., van Noorden C.J., Suchy M.T., Cobbaert C.M., Klautz R.J., Schaapherder A.F., Lindeman J.H. Oxidative damage in clinical ischemia/reperfusion injury: a reappraisal. Antioxid. Redox Signal. 2013, 19(6):535-5345.
4. Prescott L.M., Jones M.E. Modified methods for the determination of carbamyl aspartate. Anal. Biochem. 1969, 32:408-419.
5. 2-isoprostanes: markers and mediators in human disease. Curr. Pharm. Anal. 2007, 3:39-51.
6. Tain Y.L., Baylis C. Determination of dimethylarginine dimethylaminohydrolase activity in the kidney. Kidney Int. 2007, 72:886-889.
7. Trocha M., Merwid-Lad A., Chlebda-Sieragowska E., Szuba A., Pieśniewska M., Fereniec-Gołebiewska L., Kwiatkowska J., Szelag A., Sozański T. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion. Exp. Gerontol. 2014, 50C:45-51.
8. Tsikas D., Böger R.H., Sandmann J., Bode-Böger S.M., Frölich J.C. Endogenous nitric oxide synthase inhibitors are responsible for the L-arginine paradox. FEBS Lett. 2000, 478(1-2):1-3.
9. Tsikas D., Thum T., Becker T., Pham V.V., Chobanyan K., Mitschke A., Beckmann B., Gutzki F.M., Bauersachs J., Stichtenoth D.O. Accurate quantification of dimethylamine (DMA) in human urine by gas chromatography-mass spectrometry as pentafluorobenzamide derivative: evaluation of the relationship between DMA and its precursor asymmetric dimethylarginine (ADMA) in health and disease. J. Chromatogr. B 2007, 851(1-2):229-239.
10. Tsikas D., Chobanyan K. Pitfalls in the measurement of tissue DDAH activity: is DDAH sensitive to nitrosative and oxidative stress?. Kidney Int. 2008, 74(7):969.